Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Am J Ophthalmol. 2017 Dec 2;186:144–151. doi: 10.1016/j.ajo.2017.11.020

Figure 1.

Figure 1

Semi-automated choroidal segmentation of EDI-OCT images before and after suprachoroidal triamcinolone acetonide and intravitreal aflibercept injection in an eye with ME due to RVO.

Images are shown before injection (top row), and at 1 month (second row), 2 months (third row), and 3 months (bottom row) after treatment, with (left column) and without (right column) segmentation boundaries, including the inner limiting membrane (white line), RPE/Bruch’s membrane complex (purple line), vascular choroidal thickness boundary (blue line), stromal choroidal thickness boundary (yellow line), and total choroidal thickness boundary (green line). The fovea is labeled with a yellow asterisk.